PAION AG Logo

PAION AG

Developed drugs for hospital-based sedation, anesthesia, and critical care.

PA8 | F

Overview

Corporate Details

ISIN(s):
DE000A3E5EG5
LEI:
529900CGHB9UWY40BU45
Country:
Germany
Address:
Heussstraße 25, 52078 Aachen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PAION AG was a specialty pharmaceutical company focused on developing and commercializing innovative drugs for hospital-based applications, including sedation, anesthesia, and critical care. The company aimed to address unmet medical needs in both outpatient and hospital settings. Effective January 1, 2024, insolvency proceedings were opened over the company's assets, and the sale of its business operations was finalized in March 2024.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-09-29 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.0…
German 163.2 KB
2023-09-29 00:00
Interim Report
Half-yearly financial report 2023
English 699.3 KB
2023-09-27 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
German 5.7 KB
2023-06-07 00:00
Annual Report
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 879.5 KB
2023-06-01 00:00
Regulatory News Service
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 931.2 KB
2023-06-01 00:00
Regulatory News Service
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 533.1 KB
2023-05-31 00:00
Annual Report
Annual financial report 2022
English 1.8 MB
2023-05-22 00:00
Earnings Release
Q1 statement / Q1 financial report 2023
English 200.9 KB
2023-05-17 00:00
Annual Report
English 1.6 MB
2023-05-15 00:00
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
German 5.7 KB
2022-11-17 00:00
Earnings Release
Q3 statement / Q3 financial report 2022
English 110.5 KB
2022-09-05 00:00
Interim Report
Half-yearly financial report 2022
German 518.2 KB
2022-08-31 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
German 167.2 KB
2022-08-17 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
German 5.8 KB
2022-05-18 00:00
Annual Report
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
German 780.7 KB

Automate Your Workflow. Get a real-time feed of all PAION AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PAION AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PAION AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-12-27 Siebert, Gregor Board Buy None 24,110.26 EUR
2022-12-22 Dieckow, StB Simone Close relation Buy None 500,000.00 EUR
2022-12-22 Fuchs, Anna-Louisa Close relation Other None N/A
2022-12-21 Zeitfracht GmbH & Co. KGaA Close relation Buy None 3,607,500.00 EUR

Peer Companies

Greenwich LifeSciences, Inc. Logo
Developing an immunotherapy vaccine to prevent recurrence in HER2-positive breast cancer patients.
United States of America
GLSI
GRI Bio, Inc. Logo
Advancing NKT cell modulators for inflammatory, fibrotic, and autoimmune diseases.
United States of America
GRI
Grifols S.A. Logo
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain
GRF
Grindeks Logo
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia
GRD1R
GT Biopharma, Inc. Logo
Develops TriKE® immunotherapies engaging NK cells to treat hematologic and solid tumor cancers.
United States of America
GTBP
Guardant Health, Inc. Logo
Develops liquid biopsies for cancer detection, monitoring, and personalized treatment guidance.
United States of America
GH
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden
GUARD
Develops research antibodies and distributes scientific instruments for life science researchers.
South Korea
036180
GYRE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing novel drugs for liver fibrosis and pneumoconiosis.
United States of America
GYRE
Haleon PLC Logo
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom
HLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.